This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Scotts Miracle-Gro (SMG) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Scotts Miracle-Gro (SMG) have what it takes? Let's find out.
Will The Scotts Miracle-Gro Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in The Scotts Miracle-Gro.
Scotts Miracle-Gro (SMG) Misses on Q1 Earnings, Tops Sales
by Zacks Equity Research
Scotts Miracle-Gro's (SMG) Q1 margins hurt by expected increase in freight costs along with mark-to-market adjustments on fuel hedges.
Scotts Miracle-Gro (SMG) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Scotts (SMG) delivered earnings and revenue surprises of -12.10% and 1.16%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Scotts Miracle-Gro (SMG) in Q1 Earnings?
by Zacks Equity Research
Our proven model does not conclusively show a beat for Scotts Miracle-Gro (SMG) in the fiscal first quarter.
Why Scotts Miracle-Gro (SMG) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Scotts Miracle-Gro (SMG) have what it takes? Let's find out.
Fertilizers Industry Outlook: Near-Term Prospects Look Bright
by Zacks Equity Research
The fertilizer industry has gained strength, courtesy of improved pricing and demand dynamics for major crop nutrients.
Why Scotts Miracle-Gro (SMG) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Scotts Miracle-Gro (SMG) have what it takes? Let's find out.
Fertilizer Industry on Solid Footing: 3 Stocks to Buy Now
by Zacks Equity Research
Investors may want to consider these fertilizers stocks in their portfolio amid improving nutrient pricing and demand environment.
Scotts (SMG) Down 9.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Scotts (SMG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Are There Any Dividend-Paying Cannabis Stocks?
by Ryan McQueeney
Cannabis stocks have been one of the investing world's top stories in 2018, but for many, these speculative plays are far too unpredictable. Are there any stable, dividend-paying marijuana stocks to buy right now?
Scotts Miracle-Gro (SMG) Q4 Earnings and Sales Lag Estimates
by Zacks Equity Research
Scotts Miracle-Gro's (SMG) Hawthorne segment witnesses strong sales growth in Q4. It expects adjusted EPS in the band of $4.10-$4.30 for fiscal 2019.
Scotts Miracle-Gro (SMG) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Scotts (SMG) delivered earnings and revenue surprises of -11.94% and -1.98%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Scotts Miracle-Gro (SMG) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Scotts (SMG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Under-The-Radar Marijuana Stocks & News from GM, LEN, AMD | Free Lunch
by Ryan McQueeney
Ryan McQueeney discusses the Dow's record open and Jerome Powell's latest comments on the economy. He also recaps trending stories like the GM-Honda autonomous partnership, Lennar's earnings, and AMD's recent volatility. Later, Ryan highlights two under-the-radar marijuana stocks.
Fertilizers Industry Outlook: Near-Term Prospects Cloudy
by Zacks Equity Research
While the fertilizers makers are witnessing an improving nutrient demand and pricing environment, weak agricultural commodity prices and escalating trade tensions may weigh on the industry.
Nova Measuring, Scotts Miracle, PayPal and eBay highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Nova Measuring, Scotts Miracle, PayPal and eBay highlighted as Zacks Bull and Bear of the Day
Bear Of The Day: Scotts Miracle-Gro (SMG)
by Brian Bolan
Consistently lower earnings estimates have helped keep this stock a Zacks Rank #5 (Strong Sell) for months, but I still keep it on my radar screen.
What Investors Need to Know About Investing In Marijuana Stocks
by Benjamin Rains
Marijuana has come a long way since California legalized cannabis for medicinal use back in 1996. Today, the industry and marijuana look to be on the cusp of unprecedented acceptance, with major international giants investing billions into publicly traded cannabis companies. So let's take a look at what investors need to know about the marijuana industry and how to invest in the future of pot.
CRON, CGC Sink Ahead of Earnings: What To Watch From These Pot Stocks
by Benjamin Rains
Recreational marijuana is now legal in Canada as well as a number of states in the U.S. Companies have raced to get in on the multibillion-dollar a year industry, so let's see how two of the bigger pure-play pot stocks, Cronos Group (CRON) and Canopy Growth (CGC), are projected to perform Tuesday.
Where to Find the Best Marijuana Stocks
by Tracey Ryniec
The marijuana industry continues to grow and so do the investing opportunities. Where can you find them now?
Where to Find the Best Marijuana Stocks
by Tracey Ryniec
The marijuana industry continues to grow and so do the investing opportunities. Where can you find them now?
Scotts Miracle-Gro (SMG) Q3 Earnings Top, Sales Lag Estimates
by Zacks Equity Research
Scotts Miracle-Gro (SMG) reiterates its adjusted earnings outlook for fiscal 2018 in the range of $3.70-$3.90 per share.
5 Must-See Earnings Charts
by Tracey Ryniec
Interested in marijuana, fertilizers and furniture? Companies involved in those industries will be reporting this weekk
Scotts Miracle-Gro (SMG) Provides Update on FY18 Outlook
by Zacks Equity Research
For fiscal 2018, Scotts Miracle-Gro (SMG) expects adjusted earnings in the range of $3.70-$3.90 per share, including dilution associated with the Sunlight transaction.